These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 28094220)

  • 41. New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.
    Durcik M; Nyerges Á; Skok Ž; Skledar DG; Trontelj J; Zidar N; Ilaš J; Zega A; Cruz CD; Tammela P; Welin M; Kimbung YR; Focht D; Benek O; Révész T; Draskovits G; Szili PÉ; Daruka L; Pál C; Kikelj D; Mašič LP; Tomašič T
    Eur J Med Chem; 2021 Mar; 213():113200. PubMed ID: 33524686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on antibacterial agents. II. Synthesis and antibacterial activities of substituted 1,2-dihydro-6-oxo-6H-pyrrolo[3,2,1-ij]quinoline-5-carboxylic acids.
    Ishikawa H; Uno T; Miyamoto H; Ueda H; Tamaoka H; Tominaga M; Nakagawa K
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2459-62. PubMed ID: 2126749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase.
    Chopra B; Dhingra AK; Prasad DN; Bhardwaj S; Dubey S
    Curr Comput Aided Drug Des; 2020; 16(3):281-294. PubMed ID: 31288729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines.
    Werner MM; Patel BA; Talele TT; Ashby CR; Li Z; Zauhar RJ
    Bioorg Med Chem; 2015 Sep; 23(18):6125-37. PubMed ID: 26320664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibacterial Spiropyrimidinetriones with N-Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA Gyrase.
    Basarab GS; Doig P; Eyermann CJ; Galullo V; Kern G; Kimzey A; Kutschke A; Morningstar M; Schuck V; Vishwanathan K; Zhou F; Gowravaram M; Hauck S
    J Med Chem; 2020 Oct; 63(20):11882-11901. PubMed ID: 32914979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains.
    Zidar N; Onali A; Peršolja P; Benedetto Tiz D; Dernovšek J; Skok Ž; Durcik M; Cotman AE; Hrast Rambaher M; Cruz CD; Tammela P; Senerovic L; Jovanovic M; Szili PÉ; Czikkely MS; Pál C; Zega A; Peterlin Mašič L; Ilaš J; Tomašič T; Kikelj D
    Eur J Med Chem; 2024 Nov; 278():116823. PubMed ID: 39236496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of RHS moiety (Part-3).
    Singh SB; Kaelin DE; Wu J; Miesel L; Tan CM; Gill C; Black T; Nargund R; Meinke PT; Olsen DB; Lagrutta A; Wei C; Peng X; Wang X; Fukuda H; Kishii R; Takei M; Takeuchi T; Shibue T; Ohata K; Takano H; Ban S; Nishimura A; Fukuda Y
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2473-8. PubMed ID: 25978963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted potent antimicrobial benzochromene-based analogues: Synthesis, computational studies, and inhibitory effect against 14α-Demethylase and DNA Gyrase.
    Fouda AM; Hassan AH; Eliwa EM; Ahmed HEA; Al-Dies AM; Omar AM; Nassar HS; Halawa AH; Aljuhani N; El-Agrody AM
    Bioorg Chem; 2020 Dec; 105():104387. PubMed ID: 33130344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents.
    Khan T; Sankhe K; Suvarna V; Sherje A; Patel K; Dravyakar B
    Biomed Pharmacother; 2018 Jul; 103():923-938. PubMed ID: 29710509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin-1,2,4-triazole scaffolds.
    Pathak P; Novak J; Shukla PK; Grishina M; Potemkin V; Verma A
    Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000473. PubMed ID: 33656194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5).
    Singh SB; Kaelin DE; Meinke PT; Wu J; Miesel L; Tan CM; Olsen DB; Lagrutta A; Fukuda H; Kishii R; Takei M; Takeuchi T; Takano H; Ohata K; Kurasaki H; Nishimura A; Shibata T; Fukuda Y
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3630-5. PubMed ID: 26152426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent antibacterial activity of dihydydropyrimidine-1,3,5-triazines via inhibition of DNA gyrase and antifungal activity with favourable metabolic profile.
    Masih A; Shrivastava JK; Bhat HR; Singh UP
    Chem Biol Drug Des; 2020 Aug; 96(2):861-869. PubMed ID: 32333828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
    Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
    Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols.
    Priyanka ; Singh V; Ekta ; Katiyar D
    Bioorg Chem; 2017 Apr; 71():120-127. PubMed ID: 28196603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors.
    Hashem HE; Amr AEE; Nossier ES; Elsayed EA; Azmy EM
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
    Tomašič T; Katsamakas S; Hodnik Ž; Ilaš J; Brvar M; Solmajer T; Montalvão S; Tammela P; Banjanac M; Ergović G; Anderluh M; Peterlin Mašič L; Kikelj D
    J Med Chem; 2015 Jul; 58(14):5501-21. PubMed ID: 26098163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
    Fois B; Skok Ž; Tomašič T; Ilaš J; Zidar N; Zega A; Peterlin Mašič L; Szili P; Draskovits G; Nyerges Á; Pál C; Kikelj D
    ChemMedChem; 2020 Feb; 15(3):265-269. PubMed ID: 31721445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological activity of benzothiazolo[3,2-a]quinolone antibacterial agents.
    Chu DT; Fernandes PB; Pernet AG
    J Med Chem; 1986 Aug; 29(8):1531-4. PubMed ID: 3090265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
    Salem MA; Ragab A; Askar AA; El-Khalafawy A; Makhlouf AH
    Eur J Med Chem; 2020 Feb; 188():111977. PubMed ID: 31927313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.